CP
MDT icon

Camelot Portfolios’s Medtronic MDT Stock Holding History

Camelot Portfolios’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,528
Closed -$204K – 189
2017
Q1 		$204K Sell
2,528
-5,145
-67% -$402K 0.1% 163
2016
Q4 		$547K Buy
+7,673
New +$603K 0.29% 94
2016
Q1 		– Sell
-6,435
Closed -$495K – 167
2015
Q4 		$495K Buy
+6,435
New +$484K 0.32% 81
2015
Q2 		– Sell
-5,979
Closed -$466K – 178
2015
Q1 		$466K Buy
5,979
+2,739
+85% +$208K 0.27% 108
2014
Q4 		$234K Sell
3,240
-3
-0.1% -$208 0.13% 143
2014
Q3 		$201K Sell
3,243
-3,635
-53% -$231K 0.12% 149
2014
Q2 		$439K Buy
6,878
+349
+5% +$21.2K 0.28% 100
2014
Q1 		$402K Sell
6,529
-1,035
-14% -$60.3K 0.27% 96
2013
Q4 		$434K Buy
7,564
+778
+11% +$44.1K 0.28% 92
2013
Q3 		$361K Sell
6,786
-1,032
-13% -$55.5K 0.26% 95
2013
Q2 		$402K Buy
+7,818
New +$386K 0.31% 88

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Camelot Portfolios's MDT Position: Q2 2017 in Review

Camelot Portfolios sold out of Medtronic (MDT) in Q2 2017, closing a stake of 2,528 shares — an estimated $204K sold.

Camelot Portfolios first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $547K in Q4 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Camelot Portfolios reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Camelot Portfolios sold 2,528 Medtronic shares in Q2 2017, an estimated $204K.
  • Camelot Portfolios first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Camelot Portfolios's Medtronic position peaked at $547K in Q4 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Camelot Portfolios's 13F filing for Q2 2017, filed 31 Jul 2017.